Major Depression A study of the efficacy, safety and tolerability of (study medication) 25 or 50 mg given once daily in the treatment of Major Depressive Disorder (MDD) followed by a 28-week open-label treatment with (study medication) 25 or 50 mg Alzheimer’s An Open Label Study to Evaluate the Effectiveness and Safety of (study medication)) in Subjects with Mild to Severe Alzheimer’s Disease Residing in an Assisted Living Facility Alzheimer’s/Dementia: An Evaluation of the Comparative Efficacy, Safety, and Tolerability of (study medication) 10 and 15cm2 Patch in Patients with Alzheimer’s Disease Showing Cognitive Decline during an Initial Open-Label Treatment Phase A Study of (study medication) in the Treatment of Elderly Subjects with Psychosis and Behavioral Disturbances Associated with Dementia of the Alzheimer’s Type Schizophrenia: A Fixed-Dose Study of the Effect on Weight of (study medication) Versus (other medication) in the Treatment of Outpatients with Schizophrenia A Study to Compare the Effects of (study medication) and (other medication) on Weight Changes in Stable Schizophrenia Patients
|
